Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × cediranib × Clear all

NCT00588900 2017-04-05

Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

Phase 2 Terminated

5 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00278889 2012-10-24

HORIZON I

Phase 2 Completed

215 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms